Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Ghana govt to back GM cotton adoption

Ghana’s Ministry for Environment, Science and Technology has co-organised a workshop to inform cotton growers and others in the supply chain of the benefits of adopting biotechnology, the International Service for the Acquisition of Agri-Biotech Applications reports. Minister Sherry Ayittey told delegates that biotechnology held the key to solving the country’s inability to maintain cotton production levels. It has fallen by more than half since the 1990s. Farmer representatives from Burkina Faso, South Africa and India shared their experience, particularly noting savings from fewer insecticide applications. Key recommendations included: fast-tracking the development of rules for biosafety compliance; finding the right suppliers; creating an independent growers’ association; and setting international standards on the quality of seed and lint. The event was arranged by three Ministries in collaboration with the UN Industrial Development Organization. Ghana’s Biosafety Act came into force earlier this year, allowing the cultivation of GM crops.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts